EC
BEAM icon

EcoR1 Capital’s Beam Therapeutics BEAM Stock Holding History

EcoR1 Capital’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-526,685
Closed -$10.3M – 40
2025
Q1 		$10.3M Buy
+526,685
New +$13.8M 0.61% 23
2023
Q2 		– Sell
-198,591
Closed -$6.08M – 57
2023
Q1 		$6.08M Buy
+198,591
New +$7.84M 0.2% 38

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

EcoR1 Capital's BEAM Position: Q2 2025 in Review

EcoR1 Capital sold out of Beam Therapeutics (BEAM) in Q2 2025, closing a stake of 526,685 shares — an estimated $10.3M sold.

EcoR1 Capital first reported a position in BEAM in Q1 2023 and held it in 2 quarters. The position peaked at $10.3M in Q1 2025. 217 funds tracked by Wall St. Rank hold BEAM as of Q2 2025.

  • EcoR1 Capital reported no remaining Beam Therapeutics position as of Q2 2025 after selling out during the quarter.
  • EcoR1 Capital sold 526,685 Beam Therapeutics shares in Q2 2025, an estimated $10.3M.
  • EcoR1 Capital first reported a position in Beam Therapeutics in Q1 2023 and held it in 2 quarters.
  • EcoR1 Capital's Beam Therapeutics position peaked at $10.3M in Q1 2025.
  • 217 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2025.

Based on EcoR1 Capital's 13F filing for Q2 2025, filed 14 Aug 2025.